nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Red blood cell sedimentation rate increased—Ramipril—type 1 diabetes mellitus	0.0915	0.0915	CcSEcCtD
Tobramycin—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0722	0.0722	CcSEcCtD
Tobramycin—Proteinuria—Ramipril—type 1 diabetes mellitus	0.0281	0.0281	CcSEcCtD
Tobramycin—Protein urine present—Ramipril—type 1 diabetes mellitus	0.0277	0.0277	CcSEcCtD
Tobramycin—Cough increased—Ramipril—type 1 diabetes mellitus	0.0269	0.0269	CcSEcCtD
Tobramycin—Drug interaction—Ramipril—type 1 diabetes mellitus	0.0266	0.0266	CcSEcCtD
Tobramycin—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.0262	0.0262	CcSEcCtD
Tobramycin—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.0259	0.0259	CcSEcCtD
Tobramycin—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.0259	0.0259	CcSEcCtD
Tobramycin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0224	0.0224	CcSEcCtD
Tobramycin—Deafness—Ramipril—type 1 diabetes mellitus	0.02	0.02	CcSEcCtD
Tobramycin—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0196	0.0196	CcSEcCtD
Tobramycin—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.0194	0.0194	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.019	0.019	CcSEcCtD
Tobramycin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0188	0.0188	CcSEcCtD
Tobramycin—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.0168	0.0168	CcSEcCtD
Tobramycin—Asthma—Ramipril—type 1 diabetes mellitus	0.0155	0.0155	CcSEcCtD
Tobramycin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.0153	0.0153	CcSEcCtD
Tobramycin—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.0152	0.0152	CcSEcCtD
Tobramycin—Bronchitis—Ramipril—type 1 diabetes mellitus	0.0149	0.0149	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0144	0.0144	CcSEcCtD
Tobramycin—Renal failure—Ramipril—type 1 diabetes mellitus	0.0136	0.0136	CcSEcCtD
Tobramycin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0135	0.0135	CcSEcCtD
Tobramycin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.0134	0.0134	CcSEcCtD
Tobramycin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.013	0.013	CcSEcCtD
Tobramycin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0129	0.0129	CcSEcCtD
Tobramycin—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0129	0.0129	CcSEcCtD
Tobramycin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0122	0.0122	CcSEcCtD
Tobramycin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.0119	0.0119	CcSEcCtD
Tobramycin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0115	0.0115	CcSEcCtD
Tobramycin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0112	0.0112	CcSEcCtD
Tobramycin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.0112	0.0112	CcSEcCtD
Tobramycin—Erythema—Ramipril—type 1 diabetes mellitus	0.0108	0.0108	CcSEcCtD
Tobramycin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0106	0.0106	CcSEcCtD
Tobramycin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.01	0.01	CcSEcCtD
Tobramycin—Angioedema—Ramipril—type 1 diabetes mellitus	0.00985	0.00985	CcSEcCtD
Tobramycin—Malaise—Ramipril—type 1 diabetes mellitus	0.00972	0.00972	CcSEcCtD
Tobramycin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00968	0.00968	CcSEcCtD
Tobramycin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00965	0.00965	CcSEcCtD
Tobramycin—Cough—Ramipril—type 1 diabetes mellitus	0.0094	0.0094	CcSEcCtD
Tobramycin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00917	0.00917	CcSEcCtD
Tobramycin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00917	0.00917	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00911	0.00911	CcSEcCtD
Tobramycin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00906	0.00906	CcSEcCtD
Tobramycin—Confusional state—Ramipril—type 1 diabetes mellitus	0.00887	0.00887	CcSEcCtD
Tobramycin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00879	0.00879	CcSEcCtD
Tobramycin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00863	0.00863	CcSEcCtD
Tobramycin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00861	0.00861	CcSEcCtD
Tobramycin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00854	0.00854	CcSEcCtD
Tobramycin—Anorexia—Ramipril—type 1 diabetes mellitus	0.00838	0.00838	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00801	0.00801	CcSEcCtD
Tobramycin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0079	0.0079	CcSEcCtD
Tobramycin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00784	0.00784	CcSEcCtD
Tobramycin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00765	0.00765	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00759	0.00759	CcSEcCtD
Tobramycin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00725	0.00725	CcSEcCtD
Tobramycin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00719	0.00719	CcSEcCtD
Tobramycin—Urticaria—Ramipril—type 1 diabetes mellitus	0.00699	0.00699	CcSEcCtD
Tobramycin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00695	0.00695	CcSEcCtD
Tobramycin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00695	0.00695	CcSEcCtD
Tobramycin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00648	0.00648	CcSEcCtD
Tobramycin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00631	0.00631	CcSEcCtD
Tobramycin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00622	0.00622	CcSEcCtD
Tobramycin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00602	0.00602	CcSEcCtD
Tobramycin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00582	0.00582	CcSEcCtD
Tobramycin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00559	0.00559	CcSEcCtD
Tobramycin—Rash—Ramipril—type 1 diabetes mellitus	0.00555	0.00555	CcSEcCtD
Tobramycin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00554	0.00554	CcSEcCtD
Tobramycin—Headache—Ramipril—type 1 diabetes mellitus	0.00551	0.00551	CcSEcCtD
Tobramycin—Nausea—Ramipril—type 1 diabetes mellitus	0.00522	0.00522	CcSEcCtD
